Cargando…
CD19/BAFF-R dual targeted CAR T cells for treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
Chimeric antigen receptor (CAR) T cells targeting CD19 mediate potent anti-tumor effects in B cell malignancies including acute lymphoblastic leukemia (ALL), but antigen loss remains the major cause of treatment failure. To mitigate antigen escape and potentially improve durability of remission, we...
Autores principales: | Wang, Xiuli, Dong, Zhenyuan, Awuah, Dennis, Chang, Wen-Chung, Cheng, Wesley A, Vyas, Vibhuti, Cha, Soungchul, Anderson, Aaron, Zhang, Tiantian, Wang, Zhe, Szymura, Szymon, Kuang, Benjamin, Clark, Mary C., Aldoss, Ibrahim, Forman, Stephen J., Kwak, Larry W, Qin, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983465/ https://www.ncbi.nlm.nih.gov/pubmed/35039637 http://dx.doi.org/10.1038/s41375-021-01477-x |
Ejemplares similares
-
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions
por: Dong, Zhenyuan, et al.
Publicado: (2020) -
Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies
por: Dong, Zhenyuan, et al.
Publicado: (2022) -
Immortalized B Cells Transfected With mRNA of Antigen Fused to MITD (IBMAM): An Effective Immunological Tool for In-Vitro Immune-Monitoring of Antigen-specific T Cells
por: Zhang, Tiantian, et al.
Publicado: (2022) -
Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia
por: Aldoss, Ibrahim, et al.
Publicado: (2023) -
Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation
por: Wang, Zhe, et al.
Publicado: (2023)